BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23420638)

  • 1. High expression of FER tyrosine kinase predicts poor prognosis in clear cell renal cell carcinoma.
    Wei C; Wu S; Li X; Wang Y; Ren R; Lai Y; Ye J
    Oncol Lett; 2013 Feb; 5(2):473-478. PubMed ID: 23420638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β-activated kinase-1: a potential prognostic marker for clear cell renal cell carcinoma.
    Wei C; Lai YQ; Li XX; Ye JX
    Asian Pac J Cancer Prev; 2013; 14(1):315-20. PubMed ID: 23534745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.
    Cui ZW; Xia Y; Ye YW; Jiang ZM; Wang YD; Wu JT; Sun L; Zhao J; Fa PP; Sun XJ; Gui YT; Cai ZM
    Asian Pac J Cancer Prev; 2012; 13(7):3403-8. PubMed ID: 22994768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of pituitary tumor-transforming gene-1 predicts poor prognosis in clear cell renal cell carcinoma.
    Wei C; Yang X; Xi J; Wu W; Yang Z; Wang W; Tang Z; Ying Q; Zhang Y
    Mol Clin Oncol; 2015 Mar; 3(2):387-391. PubMed ID: 25798272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu S; Wang Y; Sun L; Zhang Z; Jiang Z; Qin Z; Han H; Liu Z; Li X; Tang A; Gui Y; Cai Z; Zhou F
    BMC Cancer; 2011 Sep; 11():413. PubMed ID: 21943117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rab25 expression predicts poor prognosis in clear cell renal cell carcinoma.
    Liu L; Ding G
    Exp Ther Med; 2014 Oct; 8(4):1055-1058. PubMed ID: 25187796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of pregnancy up-regulated non-ubiquitous calmodulin kinase is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu S; Lv Z; Wang Y; Sun L; Jiang Z; Xu C; Zhao J; Sun X; Li X; Hu L; Tang A; Gui Y; Zhou F; Cai Z; Wang R
    PLoS One; 2013; 8(4):e59936. PubMed ID: 23634203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma.
    Na N; Si T; Huang Z; Miao B; Hong L; Li H; Qiu J; Qiu J
    Onco Targets Ther; 2016; 9():7199-7205. PubMed ID: 27932890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
    Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X
    BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma.
    Wang W; Yu Y; Wang Y; Li X; Bao J; Wu G; Chang H; Shi T; Yue Z
    Oncol Lett; 2014 Dec; 8(6):2627-2633. PubMed ID: 25364440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.
    Peng Q; Wang L; Zhao D; Lv Y; Wang H; Chen G; Wang J; Xu W
    J Cancer; 2019; 10(5):1237-1251. PubMed ID: 30854133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
    Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
    BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum interleukin-35 levels correlate with poor prognosis in patients with clear cell renal cell carcinoma.
    Jin L; Xu X; Ye B; Pan M; Shi Z; Hu Y
    Int J Clin Exp Med; 2015; 8(10):18861-6. PubMed ID: 26770508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma.
    Ren W; Xue B; Chen M; Liu L; Zu X
    Clin Genitourin Cancer; 2019 Jun; 17(3):e433-e439. PubMed ID: 30773312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.
    Mu Z; Dong D; Sun M; Li L; Wei N; Hu B
    Front Oncol; 2020; 10():1566. PubMed ID: 33102202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.